These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 8627787

  • 1. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C, Golding B, Inman J, Blackburn R, Manischewitz J, Highet P, Golding H.
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [Abstract] [Full Text] [Related]

  • 2. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
    Golding B, Inman J, Highet P, Blackburn R, Manischewitz J, Blyveis N, Angus RD, Golding H.
    J Virol; 1995 Jun; 69(6):3299-307. PubMed ID: 7745677
    [Abstract] [Full Text] [Related]

  • 3. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD.
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [Abstract] [Full Text] [Related]

  • 4. Production of a novel antigen by conjugation of HIV-1 to Brucella abortus: studies of immunogenicity, isotype analysis, T-cell dependency, and syncytia inhibition.
    Golding B, Golding H, Preston S, Hernandez D, Beining PR, Manischewitz J, Harvath L, Blackburn R, Lizzio E, Hoffman T.
    AIDS Res Hum Retroviruses; 1991 May; 7(5):435-46. PubMed ID: 1678617
    [Abstract] [Full Text] [Related]

  • 5. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A, Nielsen HV, Bryder K, Nielsen C, Machuca R, Bruun L, Hansen J, Buus S.
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.
    Sarobe P, Lasarte JJ, Golvano JJ, Prieto I, Gullón A, Soto MJ, Labarga P, Prieto J, Borrás-Cuesta F.
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):635-40. PubMed ID: 8207641
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.
    Becker Y.
    Virus Genes; 1994 Jul; 8(3):249-70. PubMed ID: 7975271
    [Abstract] [Full Text] [Related]

  • 10. HIV peptide conjugated to heat-killed bacteria promotes antiviral responses in immunodeficient mice.
    Scott DE, Golding H, Huang LY, Inman J, Golding B.
    AIDS Res Hum Retroviruses; 1998 Sep 20; 14(14):1263-9. PubMed ID: 9764910
    [Abstract] [Full Text] [Related]

  • 11. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120.
    Nehete PN, Casement KS, Arlinghaus RB, Sastry KJ.
    Cell Immunol; 1995 Feb 20; 160(2):217-23. PubMed ID: 7720083
    [Abstract] [Full Text] [Related]

  • 12. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector.
    Gómez CE, Rodríguez D, Rodríguez JR, Abaitua F, Duarte C, Esteban M.
    Vaccine; 2001 Dec 12; 20(5-6):961-71. PubMed ID: 11738764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.
    Ratto S, Sitz KV, Scherer AM, Loomis LD, Cox JH, Redfield RR, Birx DL.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb 01; 11(2):128-36. PubMed ID: 8556394
    [Abstract] [Full Text] [Related]

  • 15. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE, Abaitua F, Rodríguez D, Esteban M.
    Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077
    [Abstract] [Full Text] [Related]

  • 16. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.
    Shiver JW, Perry HC, Davies ME, Freed DC, Liu MA.
    Ann N Y Acad Sci; 1995 Nov 27; 772():198-208. PubMed ID: 8546393
    [Abstract] [Full Text] [Related]

  • 18. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C, Stohlmann SA, McMillan M.
    Eur J Immunol; 1993 Nov 27; 23(11):2777-81. PubMed ID: 7693478
    [Abstract] [Full Text] [Related]

  • 19. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells.
    Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA.
    Int Immunol; 1993 Aug 27; 5(8):849-57. PubMed ID: 8398980
    [Abstract] [Full Text] [Related]

  • 20. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.
    Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA.
    Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):948-52. PubMed ID: 8094248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.